Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Other Operating Expenses (2016 - 2025)

Marimed (MRMD) has disclosed Other Operating Expenses for 13 consecutive years, with $8.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 10.14% to $8.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $33.5 million, a 2.19% decrease, with the full-year FY2024 number at $33.4 million, up 16.3% from a year prior.
  • Other Operating Expenses was $8.1 million for Q3 2025 at Marimed, down from $8.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $9.6 million in Q1 2025 to a low of $2.1 million in Q3 2021.
  • A 5-year average of $6.4 million and a median of $7.4 million in 2023 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 202.64% in 2021; the steepest drop was 11.49% in 2021.
  • Marimed's Other Operating Expenses stood at $3.7 million in 2021, then surged by 140.84% to $8.8 million in 2022, then dropped by 6.44% to $8.2 million in 2023, then decreased by 10.32% to $7.4 million in 2024, then rose by 8.95% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Operating Expenses are $8.1 million (Q3 2025), $8.4 million (Q2 2025), and $9.6 million (Q1 2025).